Implant Companies Pay $311 Million in Settlement

Most law firms avoid posting jobs on Indeed or LinkedIn due to high costs. Instead, they publish them on their own websites, bar association pages, and niche legal boards. LawCrossing finds these hidden jobs, giving you access to exclusive opportunities. Sign up now!

published October 08, 2007

A three-year investigation recently uncovered alleged agreements between the country's leading manufacturers of artificial hip and knee implants and orthopedic surgeons. As part of the agreements, surgeons would use the companies' products on their patients in exchange for monetary kickbacks.

According to Law.com, the Department of Health and Human Services reports that about 700,000 hip and knee replacements are performed each year, and two-thirds are performed on patients covered by Medicare.

U.S. Attorney Christopher Christie announced last week at a news conference in Newark, NJ, that "surgeons who had agreements with the companies were typically paid tens to hundreds of thousands of dollars per year for consulting contracts and often were lavished with trips and other expensive prerequisites," according to Law.com.

Christie also said that these actions were in violation of the Medicare and Medicaid Patient Protection Act of 1987, 42 U.S.C. §1320a-7b. This law deems it illegal for companies to pay doctors to sway the referral of Medicare or federal healthcare business.

As a result, four of the country's leading hip and knee implant manufacturers recently agreed to pay the federal government $311 million in fines to avoid prosecution for allegedly paying surgeons to use their products. The companies include Biomet, the DePuy Orthopaedics unit of Johnson & Johnson, Zimmer Holdings, and Smith & Nephew.

The four companies were charged with criminal conspiracy to violate anti-kickback laws. However, by paying the settlement fees and complying with procedures under federal monitoring for 18 months, they will not face prosecution.

According to The New York Times, an additional company, Stryker Orthopedics Inc., also agreed to be monitored but chose not to settle with the other companies. Stryker Orthopedics was not charged with conspiracy, as it was "the first to cooperate in the investigation."
United States

Together, the five large companies account for almost 95% of the hip and knee implant market.

According to Law.com, FBI Special Agent in Charge Weysan Dun said, "This fraud affects the price and quality of healthcare. It's just as significant as a corruption investigation and ensures that doctors' decisions are based on a patient's best interest, not their wallet."

The manufacturers also agreed that for a period of five years, they would report any payments that they make to surgeons, in addition to providing training programs that will encourage fair and ethical practices.

Under the settlement terms Zimmer will pay $169.5 million, DePuy will pay $84.7 million, Smith & Nephew will pay $28.9 million, and Biomet will pay $26.9 million.

According to Law.com, Christie said that about 50% of the fines will go to the Medicare Trust Fund and the rest will pay settlement costs.
Gain an advantage in your legal job search. LawCrossing uncovers hidden positions that firms post on their own websites and industry-specific job boards—jobs that never appear on Indeed or LinkedIn. Don't miss out. Sign up now!

( 8 votes, average: 3.7 out of 5)

What do you think about this article? Rate it using the stars above and let us know what you think in the comments below.